» Authors » Kazumi Takishima

Kazumi Takishima

Explore the profile of Kazumi Takishima including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 56
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogata N, Maeda Y, Misawa M, Takenaka K, Takabayashi K, Iacucci M, et al.
J Crohns Colitis . 2024 Jun; 19(1. PMID: 38828734
Backgrounds And Aims: The Mayo endoscopic subscore [MES] is the most popular endoscopic disease activity measure of ulcerative colitis [UC]. Artificial intelligence [AI]-assisted colonoscopy is expected to reduce diagnostic variability...
2.
Barua I, Wieszczy P, Kudo S, Misawa M, Holme O, Gulati S, et al.
NEJM Evid . 2024 Feb; 1(6):EVIDoa2200003. PMID: 38319238
BACKGROUND: Artificial intelligence using computer-aided diagnosis (CADx) in real time with images acquired during colonoscopy may help colonoscopists distinguish between neoplastic polyps requiring removal and nonneoplastic polyps not requiring removal....
3.
Kuroki T, Maeda Y, Kudo S, Ogata N, Iacucci M, Takishima K, et al.
Gastrointest Endosc . 2024 Jan; 100(1):97-108. PMID: 38215859
Background And Aims: Image-enhanced endoscopy has attracted attention as a method for detecting inflammation and predicting outcomes in patients with ulcerative colitis (UC); however, the procedure requires specialist endoscopists. Artificial...
4.
Hirai M, Yanai S, Kunisaki R, Nishio M, Watanabe K, Sato T, et al.
Gastrointest Endosc . 2023 Jun; 98(5):806-812. PMID: 37263363
Background And Aims: Patients with ulcerative colitis (UC) are at risk of developing colorectal cancer. The feasibility of endoscopic resection (ER) for UC-associated neoplasia has been suggested, but its efficacy...
5.
Maeda Y, Kudo S, Ogata N, Kuroki T, Takashina Y, Takishima K, et al.
Dig Endosc . 2022 Apr; 34(7):1297-1310. PMID: 35445457
Objectives: Advances in endoscopic technology, including magnifying and image-enhanced techniques, have been attracting increasing attention for the optical characterization of colorectal lesions. These techniques are being implemented into clinical practice...
6.
Takishima K, Maeda Y, Ogata N, Misawa M, Mori Y, Homma M, et al.
Dig Endosc . 2021 Nov; 34(5):1030-1039. PMID: 34816494
Objectives: Complete endoscopic healing, defined as Mayo endoscopic score (MES) = 0, is an optimal target in the treatment of ulcerative colitis (UC). However, some patients with MES = 0...
7.
Maeda Y, Kudo S, Ogata N, Misawa M, Iacucci M, Homma M, et al.
Gastrointest Endosc . 2021 Oct; 95(4):747-756.e2. PMID: 34695422
Background And Aims: The use of artificial intelligence (AI) during colonoscopy is attracting attention as an endoscopist-independent tool to predict histologic disease activity of ulcerative colitis (UC). However, no study...
8.
Maeda Y, Kudo S, Takishima K, Misawa M, Ogata N, Ohtsuka K
Aliment Pharmacol Ther . 2021 Mar; 53(8):955-956. PMID: 33745170
No abstract available.
9.
Kudo S, Maeda Y, Ogata N, Misawa M, Ogawa Y, Takishima K, et al.
Dig Endosc . 2021 Feb; 34(1):133-143. PMID: 33641190
Objectives: Ulcerative colitis-associated neoplasias (UCAN) are often flat with an indistinct boundary from surrounding tissues, which makes differentiating UCAN from non-neoplasias difficult. Pit pattern (PIT) has been reported as one...